Related Experiment Videos
Abstract:
Infectious mononucleosis (IM) is usually considered a benign disease. Agranulocytosis developed in a young college student 14 days after the onset of IM. Fulminant staphylococcal pneumonia and bilateral pulmonary infarcts resulted, and the patient died 4 1/2 hours after admission to a hospital. Agranulocytosis secondary to IM may be more prevalent than previously thought. A review of the literature indicated that infection developed in 57.9% of the patients with IM and extreme neutropenia and 45.4% of the infected patients died.
Insights
Infectious mononucleosis (IM) can lead to agranulocytosis, a dangerous drop in white blood cells. This rare complication significantly increases the risk of severe infections and mortality, challenging IM's benign perception.
Area of Science:
- Infectious Diseases
- Hematology
- Immunology
Background:
- Infectious mononucleosis (IM), typically caused by Epstein-Barr virus, is generally regarded as a self-limiting illness.
- While IM is known for potential hematological complications, severe neutropenia is not commonly emphasized.
Observation:
- A case study of a young college student who developed agranulocytosis 14 days post-IM onset.
- The patient subsequently presented with fulminant staphylococcal pneumonia and bilateral pulmonary infarcts.
Findings:
- Agranulocytosis secondary to IM may be more common than previously recognized.
- Literature review revealed infection in 57.9% of patients with IM and extreme neutropenia.
- Mortality rate among infected patients with IM-associated neutropenia was 45.4%.
Implications:
- The findings suggest a need to reconsider the potential severity of IM.
- Increased awareness of IM-associated agranulocytosis is crucial for early diagnosis and intervention.
- This highlights the importance of monitoring for hematological complications in IM patients, especially those with neutropenia.